Johnson & Johnson
NYSEJohnson & Johnson slipped 0.8% on the week to close at $235.18, a modest pullback after the stock's strongest four-week run in over a year — and with Q2 earnings now less than four weeks away, options traders are quietly adding more downside cover than they've carried for most of 2026. The clearest read on market sentiment this week comes from the options market. The put/call ratio…
Snapshot as of 22 Jun 2026
A new long-form analysis for JNJ this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumJohnson & Johnson slipped 0.8% on the week to close at $235.18, a modest pullback after the stock's strongest four-week run in over a year — and with Q2 earnings now less than four weeks away, options traders are…
Johnson & Johnson has extended its post-Firefly momentum, adding another 6.3% this week to close at $237 — and the focus is now shifting from the acquisition narrative to what the July 14 earnings print will…
Johnson & Johnson has stabilised at $222.89 this week, but the short-selling story that defined last week's note has taken a twist — shorts are pulling back even as the stock continues to slide. Last week's report…
Johnson & Johnson enters the back half of May with fresh analyst momentum but a stock that has given back 6% over the past month — a tension that sets up an interesting read on where the market is willing to take a…
Johnson & Johnson enters the second week of May having shed a month's worth of bearish positioning, even as the stock itself is down 7% from a month ago — a divergence that sits at the heart of this week's setup. The…
Johnson & Johnson heads into the final day of April with the story squarely about one thing: a decisive unwinding of short positions that began during the tariff-shock selloff and accelerated through Q1 earnings…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
Sign up for free →Open JNJ on ORTEX